MFDS
- Status: likely_approved
🇰🇷 Aureomycin in South Korea
Aureomycin (CHLORTETRACYCLINE) regulatory status in South Korea.
Marketing authorisation
Aureomycin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Aureomycin approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Aureomycin in South Korea?
Marketing authorisation holder not available in our data.